metformin has been researched along with Bladder Diseases in 2 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oliveira, AL | 1 |
| de Oliveira, MG | 1 |
| Medeiros, ML | 1 |
| Mónica, FZ | 1 |
| Antunes, E | 1 |
| Wang, Z | 1 |
| Cheng, Z | 1 |
| Cristofaro, V | 1 |
| Li, J | 1 |
| Xiao, X | 1 |
| Gomez, P | 1 |
| Ge, R | 1 |
| Gong, E | 1 |
| Strle, K | 1 |
| Sullivan, MP | 1 |
| Adam, RM | 1 |
| White, MF | 1 |
| Olumi, AF | 1 |
2 other studies available for metformin and Bladder Diseases
| Article | Year |
|---|---|
Metformin abrogates the voiding dysfunction induced by prolonged methylglyoxal intake.
Topics: Administration, Oral; Animals; Disease Models, Animal; Glycation End Products, Advanced; Humans; Mal | 2021 |
Inhibition of TNF-α improves the bladder dysfunction that is associated with type 2 diabetes.
Topics: Animals; Diabetes Mellitus, Type 2; Disease Models, Animal; Insulin Receptor Substrate Proteins; Met | 2012 |